[Federal Register: March 23, 2004 (Volume 69, Number 56)]
[Notices]
[Page 13559-13563]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23mr04-91]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Funding Opportunity Title: Residential Treatment for Pregnant and
Postpartum Women and Residential Treatment for Women and Their Children
(Short Title: PPW/RWC)
Announcement Type: Initial.
Funding Opportunity Number: TI 04-004.
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243.
Due Date for Applications: June 2, 2004.
(Note: Letters from State Single Point of Contact (SPOC) in
response to E.O. 12372 are due August 2, 2004.)
SUMMARY: The Substance Abuse and Mental Health Services Administration
(SAMHSA), Center for Substance Abuse Treatment (CSAT), announces the
availability of FY 2004 funds for Residential Treatment for Pregnant
and Postpartum Women and Residential Treatment for Women and Their
Children (Short Title: PPW/RWC). A synopsis of this funding
opportunity, as well as many other Federal Government funding
opportunities, are also available at the Internet site: http://www.grants.gov
.
For complete instructions, potential applicants must obtain a copy
of SAMHSA's standard Services Grants Program Announcement (SVC-04 PA
(MOD)), and the PHS 5161-1 (Rev. 7/00) application form before
preparing and submitting an application. The SVC-04 PA (MOD) describes
the general program design and provides instructions for applying for
all SAMHSA Services Grants, including the PPW/RWC program. SAMHSA's
Services Grants provide funds to expand and strengthen effective,
culturally appropriate substance abuse and mental health services at
the State and local levels. The services implemented through SAMHSA's
Services Grants must incorporate the best objective information
available regarding effectiveness and acceptability. In general, these
grants are appropriate for applicants seeking Federal support to
implement substance abuse and mental health services that have a strong
evidence-base for effectiveness. SAMHSA's Services Grants must be used
primarily to support direct service delivery. SAMHSA expects that the
services will be sustained beyond the term of the grant. Additional
instructions and specific requirements for this funding opportunity are
described below.
I. Funding Opportunity Description
Authority: Section 509 of the Public Health Service Act, as
amended and subject to the availability of funds.
The purpose of PPW/RWC grants is to expand the availability of
comprehensive, high quality residential substance abuse treatment
services for low-income (as defined by Federal poverty definitions)
women, age 18 and over, who are pregnant, postpartum (the period after
childbirth up to12 months), or other parenting women, and their minor
children, age 17 and under, who
[[Page 13560]]
have limited access to quality health services. SAMHSA/CSAT has
identified traditionally underserved populations, especially racial and
ethnic minority women, as important subpopulations.
For purposes of this grant announcement, residential treatment
programs are programs that offer organized substance abuse treatment
services that feature a planned regimen of care in a safe 24-hour
residential setting with staff supervision. If treatment services are
provided off-site, they must be well coordinated and integrated to
ensure that specific aspects of the individual treatment plan and
services for the children can be addressed in both facilities. Such
services must be coupled with access to primary health, mental health
and social services for pregnant, postpartum, and other parenting women
who suffer from alcohol and drug use problems, and for their minor
children impacted by the perinatal and environmental effects of
maternal substance use and abuse. These systems of care must be
designed to improve the overall treatment outcomes for the woman, her
children, and the family unit as a whole. For those minor children who
do not reside in the treatment facility, it is important that they are
actively engaged in the treatment process with their mothers.
Applicants are required to: (1) Identify state-of-the-art clinical and
service delivery approaches that are gender-specific and culturally
appropriate for women and their minor children; and (2) utilize
effective strategies for outreach, engagement, and retention of women
in treatment.
Projects must expand or create additional treatment services that
contribute to a comprehensive continuum of care. To accomplish a
comprehensive service system, SAMHSA/CSAT expects that applicant
organizations will need to partner with other organizations. As
evidence of these partnerships, SAMHSA/CSAT requires applicants to have
written memoranda of understanding/agreement (MOU/MOA) signed by the
authorizing official in all partnership agencies and organizations that
are critical to the success of the project. These partnership agencies
and organizations may include local public housing authorities (for
permanent housing for families), child welfare, health, mental health,
and child serving agencies, family court, criminal justice, employment
and education programs, and other public and private partners.
Background: According to the 1999 National Household Survey on Drug
Abuse (NHSDA), almost 4 percent of pregnant females aged 15 to 44 used
illicit drugs (i.e., marijuana, including hashish; cocaine, including
crack; heroin; hallucinogens, including PCP and LSD; inhalants; or any
prescription-type psychotherapeutic used non-medically) during the
month before the survey. Of these, 3.4 percent of pregnant females aged
15 to 44 had used a single illicit drug in the past month, and 0.3
percent had used two or more drugs.
A recent NIDA study shows that children exposed to alcohol and
illicit drugs are at-risk for birth defects, mental retardation, and
later behavioral and learning difficulties. Other studies reveal that
children who are raised by drug abusing adults tend to exhibit a wide
range of developmental, mental health and behavioral problems, and are
themselves at higher risk for using alcohol and other drugs.
SAMHSA/CSAT is especially concerned about the high morbidity and
mortality rates of African American pregnant women and their infants.
African American pregnant women tend to use illicit drugs at a higher
rate than any other population of pregnant women. Data from the 2002
National Survey on Drug Use and Health found that among pregnant women
15 to 44 years of age, 6.2 percent of African American women reported
illicit drug use in the month prior to survey compared to 3.6 percent
of white women. The effects of illicit drug use by women during the
prenatal period are well documented in the literature to include
inadequate prenatal care, premature labor, low birth weight infants,
and other adverse outcomes. The National Center for Health Statistics
reports persistent racial/ethnic disparities in infant mortality. From
1997-2001, the infant mortality rate for babies born to African
American mothers was 14.0 per 1000 births while the rate for babies
born to Caucasian mothers was 5.7 per 1000.
A CSAT cross-site evaluation study of PPW/RWC projects found
strikingly positive treatment outcomes on low birth weight (LBW)
deliveries, premature deliveries, and infant deaths. These outcomes
were compared to outcomes for women in the general population and to
the best available estimates of the rates of adverse outcomes that
would have been likely had women continued abusing drugs throughout
their pregnancies. The rate of LBW delivery among women in treatment
was 5.8% compared to 7.5% for a national sample, and 34% for a
comparison of women testing positive for cocaine at delivery. The rate
of premature delivery among women in treatment was 7.3% compared to the
national sample of 11.4% and a cocaine-using sample of 27%. The rate of
infant death for women in treatment was 0.4% compared to the national
sample of 0.7% and the cocaine-using sample of 1.2%.
The effects of alcohol and drug use have negative consequences for
women, their children, and the entire family. Providing comprehensive
treatment services significantly improves the quality of life for women
and their children.
II. Award Information
1. Estimated Funding Available/Number of Awards: It is expected
that up to $7 million will be available to fund up to 14 awards in FY
2004. The maximum allowable award is $500,000 in total costs (direct
and indirect) per year for up to 3 years. Proposed budgets cannot
exceed the allowable amount in any year of the proposed project. The
actual amount available for the awards may vary, depending on
unanticipated program requirements and the number and quality of the
applications received. Annual continuations will depend on the
availability of funds, grantee progress in meeting program goals and
objectives, and timely submission of required data and reports.
2. Funding Instrument: Grant.
III. Eligibility Information
1. Eligible Applicants are domestic public and private nonprofit
entities. For example, State, local or tribal governments; public or
private universities and colleges; community- and faith-based
organizations; and tribal organizations may apply. The statutory
authority for this program prohibits grants to for-profit
organizations.
Applications for SAMHSA Services Grants must include evidence of
experience and credentials as described in Section III-3 of the SVC-04
PA (MOD). Applications that do not include the required evidence will
be screened out and will not be reviewed.
2. Cost Sharing or Matching is not required.
3. Other: Applicants must also meet certain application formatting
and submission requirements or the application will be screened out and
will not be reviewed. These requirements are described in Section IV-2
below as well as in the SVC-04 PA (MOD).
IV. Application and Submission Information
1. Address to Request Application Package: Complete application
kits may be obtained from: the National Clearinghouse for Alcohol and
Drug Information (NCADI) at 1-800-729-
[[Page 13561]]
6686. When requesting an application kit for this program, the
applicant must specify the funding opportunity title (PPW/RWC) and the
funding opportunity number (TI 04-004). All information necessary to
apply, including where to submit applications and application deadline
instructions, is included in the application kit. The PHS 5161-1
application form is also available electronically via SAMHSA's World
Wide Web Home Page: http://www.samhsa.gov. (Click on `Grant
Opportunities') and the SVC-04 PA (MOD) is available electronically at
http://www.samhsa.gov/grants/2004/standard/Services/index.asp. When
submitting an application, be sure to type ``TI 04-004, PPW/RWC'' in
Item Number 10 on the face page of the application form. Also, SAMHSA
applicants are required to provide a DUNS Number on the face page of
the application. To obtain a DUNS Number, access the Dun and Bradstreet
web site at http://www.dunandbradstreet.com or call 1-866-705-5711.
Because grantees in the PPW/RWC program may use grant funds to
provide direct substance abuse services, applicants are required to
complete the Assurance of Compliance with SAMHSA Charitable Choice
Statutes and Regulations, form SMA 170. This form will be posted on
SAMHSA's web site with the NOFA and provided in the Application kits
available at NCADI.
2. Content and Form of Application Submission: Information
including required documents, required application components, and
application formatting requirements is available in the SVC-04 PA (MOD)
in Section IV-2.
Checklist for Application Formatting Requirements
SAMHSA's goal is to review all applications submitted for grant
funding. However, this goal must be balanced against SAMHSA's
obligation to ensure equitable treatment of applications. For this
reason, SAMHSA has established certain formatting requirements for its
applications. If you do not adhere to these requirements, your
application will be screened out and returned to you without review.
Use the PHS 5161-1 application.
Applications must be received by the application
deadline. Applications received after this date must have a proof of
mailing date from the carrier dated at least 1 week prior to the due
date. Private metered postmarks are not acceptable as proof of timely
mailing. Applications not received by the application deadline or not
postmarked at least 1 week prior to the application deadline will not
be reviewed.
Information provided must be sufficient for
review.
Text must be legible.
Type size in the Project Narrative cannot exceed
an average of 15 characters per inch, as measured on the physical page.
(Type size in charts, tables, graphs, and footnotes will not be
considered in determining compliance.)
Text in the Project Narrative cannot exceed 6
lines per vertical inch.
Paper must be white paper and 8.5 inches by 11.0
inches in size.
To ensure equity among applications, the amount
of space allowed for the Project Narrative cannot be exceeded.
Applications would meet this requirement by
using all margins (left, right, top, bottom) of at least one inch each,
and adhering to the page limit for the Project Narrative stated in the
SVC-04 PA (MOD).
Should an application not conform to these
margin or page limits, SAMHSA will use the following method to
determine compliance: The total area of the Project Narrative
(excluding margins, but including charts, tables, graphs and footnotes)
cannot exceed 58.5 square inches multiplied by the page limit. This
number represents the full page less margins, multiplied by the total
number of allowed pages.
Space will be measured on the physical page.
Space left blank within the Project Narrative (excluding margins) is
considered part of the Project Narrative, in determining compliance.
The page limit for Appendices stated in the SVC-
04 PA (MOD) cannot be exceeded.
To facilitate review of your application, follow these additional
guidelines. Failure to adhere to the following guidelines will not, in
itself, result in your application being screened out and returned
without review. However, the information provided in your application
must be sufficient for review. Following these guidelines will help
ensure your application is complete, and will help reviewers to
consider your application.
The 10 application components required for
SAMHSA applications should be included. These are:
Face Page (Standard Form 424, which is in PHS 5161-
1)
Abstract
Table of Contents
Budget Form (Standard Form 424A, which is in PHS
5161-1)
Project Narrative and Supporting Documentation
Appendices
Assurances (Standard Form 424B, which is in PHS
5161-1)
Certifications (a form in PHS 5161-1)
Disclosure of Lobbying Activities (Standard Form
LLL, which is in PHS 5161-1)
Checklist (a form in PHS 5161-1)
Applications should comply with the following
requirements:
Provisions relating to confidentiality,
participant protection and the protection of human subjects, as
indicated in the SVC-04 PA (MOD).
Budgetary limitations as indicated in Sections
I, II, and IV-5 of the SVC-04 PA (MOD).
Documentation of nonprofit status as required in
the PHS 5161-1.
Pages should be typed single-spaced with one
column per page.
Pages should not have printing on both sides.
Please use black ink, and number pages
consecutively from beginning to end so that information can be located
easily during review of the application. The cover page should be page
1, the abstract page should be page 2, and the table of contents page
should be page 3. Appendices should be labeled and separated from the
Project Narrative and budget section, and the pages should be numbered
to continue the sequence.
Send the original application and two copies to
the mailing address in the funding announcement. Please do not use
staples, paper clips, and fasteners. Nothing should be attached,
stapled, folded, or pasted. Do not use heavy or lightweight paper, or
any material that cannot be copied using automatic copying machines.
Odd-sized and oversized attachments such as posters will not be copied
or sent to reviewers. Do not include videotapes, audiotapes, or CD-
ROMs.
3. Submission Dates and Times: Applications must be received by
June 2, 2004. You will be notified by postal mail that your application
has been received. Additional submission information is available in
the SVC-04 PA (MOD) in Section IV-3.
4. Intergovernmental Review: Applicants for this funding
opportunity must comply with Executive Order 12372 (E.O.12372).
E.O.12372, as implemented through Department of Health and Human
Services (DHHS) regulation at 45 CFR Part 100, sets up a system for
State and local review of applications for Federal financial
assistance. Instructions for complying with E.O. 12372 are provided in
the SVC-04 PA (MOD) in Section IV-4. A current listing of State Single
Points of
[[Page 13562]]
Contact (SPOCs) is included in the application kit and is available at
http://www.whitehouse.gov/omb/grants/spoc.html.
5. Funding Restrictions: Information concerning funding
restrictions is available in the SVC-04 PA (MOD) in Section IV-5.
V. Application Review Information
1. Evaluation Criteria: Applications will be reviewed against the
Evaluation Criteria and requirements for the Project Narrative
specified in the SVC-04 PA (MOD). The following information describes
exceptions or limitations to the SVC-04 PA (MOD) and provides special
requirements that pertain only to PPW/RWC grants. Applicants must
discuss the following requirements in their applications, in addition
to the requirements specified in the SVC-04 PA (MOD):
1.1 In ``Section B: Proposed Evidence-Based Service/Practice'':
a. Applicants must demonstrate that residential treatment services
will be provided to pregnant, postpartum, or other parenting women and
their minor children.
b. Applicants must identify state-of-the art clinical and service
delivery approaches that are gender-specific and culturally appropriate
for women and also age appropriate for their minor children. Applicants
must also discuss effective strategies for outreach, engagement, and
retention of women in treatment.
1.2 In ``Section C: Proposed Implementation Approach'':
a. Applicants are not required to respond to the 4th bullet related
to how project components will be embedded within the existing service
delivery system.
b. Applicants must describe a comprehensive service system of care
that includes the required services described below. These services
must be provided either by the applicant organization or through a
network of provider organizations in partnership with the applicant. In
Appendix 6 of the application, applicants must show evidence of all
network partners by including memoranda of understanding/memoranda of
agreement (MOU/MOA) signed by the authorizing official in all
partnership agencies and organizations critical to the success of the
proposed project. If an organization is a comprehensive service
provider, does not require any partnering with other service providers,
and has clearly justified this in the description of how the required
services are provided, a statement to this effect must be provided in
Appendix 6. [Note: For purposes of rating the evidence of a
comprehensive system of care, including who performs the required
services, and the signed MOU/MOAs with network partners (if
applicable), reviewers will be instructed to use 12 of the total 25
points allowed for the entire ``Proposed Implementation Approach''
criterion for this single critical requirement. You may include letters
of commitment/support from community organizations supporting the
project in Appendix 1 of the application; however these letters are not
a substitute for the MOU/MOA requirement.]
Required Services for Women
Outreach, screening, and assessment;
Detoxification;
Substance abuse education and treatment;
Medical, dental, other physical health care
services, including diabetes, hypertension, prenatal and postpartum
health care; and referrals for necessary hospital services;
Training in parenting;
Education, screening, counseling, and treatment
of Hepatitis, HIV/AIDS, other STDs, and related issues;
Mental health assessment and treatment;
Trauma-informed services, including assessment
and interventions for emotional, sexual, and physical abuse;
Employment readiness, training, and placement;
Education and tutoring assistance for obtaining
a GED and higher education;
Childcare during periods in which the woman is
engaged in therapy or in other necessary health or rehabilitative
activities; and
Transportation and other wraparound services.
Required Services for Children
Screenings and developmental diagnostic
assessments regarding the social, emotional, cognitive, and physical
status of the infants and children;
Therapeutic interventions, including counseling,
occupational, and physical therapies;
Pediatric health care, including immunizations,
and treatment for asthma, diabetes, hypertension, and any perinatal
effects of maternal substance abuse, e.g., HIV;
Social services and financial supports; and
Education and recreational services.
Required Services for the Family
Individual and family counseling/therapy;
Alcohol and drug education;
Parenting training; and
Referral services for substance abuse, social,
psychological, and medical services.
Required Case Management Services
Coordinate services;
Assess and monitor the extent to which required
services are appropriate for women and children;
Assist with community reintegration, before and
after discharge, including referrals to appropriate resources; and
Assist in accessing resources from Federal,
State, and local programs that provide a range of treatment services,
including substance abuse, health, mental health, housing, employment,
education, and training.
1.3 In ``Section E: Evaluation and Data'' the following
requirements are added to the end of the 6th bullet: Applicants must
state whether or not the per person costs are within the following
reasonable ranges by treatment modality. Applicants must also discuss
the reasonableness of the per person costs. If proposed costs exceed
reasonable ranges, a detailed justification must be provided.
Program costs. The following are considered reasonable ranges by
treatment modality:
Residential: $3,000 to $10,000
Outpatient (Non-Methadone): $1,000 to $5,000
Outpatient (Methadone): $1,500 to $8,000
Intensive Outpatient: $1,500 to $7,500
Screen/Brief Intervention/Brief Treatment/Outreach/Pretreatment
Services: $200 to $1,200
SAMHSA/CSAT computes per person costs as follows. The total support
requested for the life of the project is multiplied by .8 (.2 will be
the allowance for GPRA reporting requirements). The resulting amount is
then be divided by the number of persons the applicant proposes to
serve over the life of the project.
The outreach and pretreatment services cost band only applies to
outreach and pretreatment programs that do not also offer treatment
services but operate within a network of substance abuse treatment
facilities. Treatment programs that add outreach and pretreatment
services to a treatment modality or modalities are expected to fall
within the cost band for that treatment modality.
1.4 Appendix 6: Memoranda of Understanding/Agreement: [Note:
Appendix 6 is in addition to the 5 required appendices listed in SVC-04
[[Page 13563]]
PA (MOD).] To achieve a comprehensive service system, SAMHSA/CSAT
expects that applicant organizations will need to partner with other
organizations, including those providing primary health, mental health,
and social services. Memoranda of understanding/agreement (MOU/MOA)
signed by the authorizing official in all partnership agencies and
organizations that are critical to the success of the project must be
included in Appendix 6, ``Memoranda of Understanding/Agreement'' of the
application. If the applicant organization is a comprehensive service
provider and does not require any partnering with other service
organizations, a statement to that effect must be included in Appendix
6 of the application. Letters of commitment/support are not a
substitute for the MOU/MOA requirement.
1.5 Performance Measurement: All SAMHSA grantees are required to
collect and report certain data, so that SAMHSA can meet its
obligations under the Government Performance and Results Act (GPRA).
Grantees of the PPW/RWC program will be required to report performance
in several areas. Applicants must document their ability to collect and
report the required data in ``Section E: Evaluation and Data'' of their
applications. All PPW/RWC grant applicants must document their ability
to collect and report data using the Targeted Capacity Expansion Client
Level GPRA tool, which can be found at http://www.csat-gpra.samhsa.gov
(click on ``Data Collection Tools/Instructions''), along with
instructions for completing it. Hard copies are available in the
application kits distributed by SAMHSA's National Clearinghouse for
Alcohol and Drug Information. GPRA data must be collected at baseline
(i.e., the client's entry into the project), 6 months after the
baseline, and 12 months after the baseline. Projects serving
adolescents also must collect 3-month post-baseline data to capture the
nuances of change particular to this population. GPRA data must be
entered into the GPRA web system within 7 business days of the forms
being completed. In addition, 80% of the participants must be followed
up. GPRA data are to be collected and then entered into CSAT's GPRA
Data Entry and Reporting System (http://www.csat-gpra.samhsa.gov).
Training and technical assistance on data collecting, tracking, and
follow-up, as well as data entry, will be provided by CSAT. Applicants
may also be required to collect additional data to determine the degree
of SAMHSA/CSAT effectiveness in meeting its objectives for this
program.
2. Review and Selection Process: Information about the review and
selection process is available in the SVC-04 PA (MOD) in Section V-2.
VI. Award Administration Information
Award administration information, including award notices,
administrative and national policy requirements, and reporting
requirements are available in the SVC-04 PA (MOD) in Section VI.
SAMHSA's standard terms and conditions are available at http://www.samhsa.gov/grants/2004/useful_info.asp
.
VII. Agency Contact for Additional Information
For questions concerning program issues, contact Linda White Young,
SAMHSA/CSAT, 5600 Fishers Lane, Rockwall II, Suite 740, Rockville, MD
20857; (301) 443-8392; E-mail: Lwhite1@samhsa.gov. For questions on
grants management issues, contact Kathleen Sample, SAMHSA/Division of
Grants Management, 5600 Fishers Lane, Rockwall II, Suite 630,
Rockville, MD 20857; (301) 443-9667; E-mail: ksample@samhsa.gov.
Dated: March 17, 2004.
Margaret M. Gilliam,
Acting Director, Office of Policy Planning and Budget, Substance Abuse
and Mental Health Services Administration.
[FR Doc. 04-6375 Filed 3-22-04; 8:45 am]
BILLING CODE 4162-20-P